2025 HCPCS Code G9018
Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project)
TAGS: demonstration inhalation through administered| Notice | HCPCS G9018 terminated on December 31, 2019. |
| Short Description | Zanamivir,inhalation pwd 10m |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | December 01, 2004 |
| HCPCS Action Effective Date | January 01, 2020 |
| HCPCS Pricing Indicator Code | 13 - Price established by carriers (e.G., not otherwise classified, individual determination, carrier discretion) |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- G9034 - Zanamivir, inh pwdr, brand
- G9035 - Oseltamivir phosp, brand
- G9036 - Rimantadine hcl, brand
- G9037 - Intrpro req fr rec phys/qhcp
- G9038 - Co-management services
- G9050 - Oncology work-up evaluation
- G9051 - Oncology tx decision-mgmt
- G9052 - Onc surveillance for disease
- G9053 - Onc expectant management pt
- G9054 - Onc supervision palliative
- G9055 - Onc visit unspecified nos
- G9056 - Onc prac mgmt adheres guide
- G9057 - Onc pract mgmt differs trial
- G9058 - Onc prac mgmt disagree w/gui
- G9059 - Onc prac mgmt pt opt alterna
- G9060 - Onc prac mgmt dif pt comorb
- G9061 - Onc prac cond noadd by guide
- G9062 - Onc prac guide differs nos
- G9063 - Onc dx nsclc stgi no progres
- G9064 - Onc dx nsclc stg2 no progres